Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice

Brain Research

Volumn 1262, Issue , 2009, Pages 100-108

  Hua, Fang ^a,c   Ma, Jing ^a   Ha, Tuanzhu ^a   Kelley, Jim L ^a   Kao, Race L ^a   Schweitzer, John B ^a   Kalbfleisch, John H ^b   Williams, David L ^a   Li, Chuanfu ^a  

^a East Tennessee State University   (United States)

^b EAST TENNESSEE STATE UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral; Ischemia reperfusion; Mouse; TLR2; TLR4

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; KNOCKOUT MOUSE; MALE; MORTALITY; MOUSE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACUTE DISEASE; ANIMALS; BRAIN; BRAIN ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-AKT; REPERFUSION INJURY; STROKE; SURVIVAL RATE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 61849088960     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.01.018     Document Type: Article

References (38)

1. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
2. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
3. Anderson K.V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12 (2000) 13-19
4. Aprahamian C.J., Lorenz R.G., Harmon C.M., and Dimmit R.A. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr. Crit. Care Med. 9 (2008) 105-109
5. Cao C.X., Yang Q.W., Lv F.L., Cui J., Fu H.B., and Wang J.Z. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353 (2007) 509-514
6. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., and Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115 (2007) 1599-1608
7. Caso J.R., Pradillo J.M., Hurtado O., Leza J.C., Moro M.A., and Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke 39 (2008) 1314-1320
8. Cavanaugh J.E. Role of extracellular signal regulated kinase 5 in neuronal survival. Eur. J. Biochem. 271 (2004) 2056-2059
9. De Simoni M.G., Milia P., Barba M., De Luigi A., Parnetti L., and Gallai V. The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients. Clin. Exp. Hypertens. 24 (2002) 535-542
10. Endo H., Nito C., Kamada H., Nishi T., and Chan P.H. Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 26 (2006) 1479-1489
11. Garcia J.H., Wagner S., Liu K.F., and Hu X.J. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 26 (1995) 627-634
12. Harper S.J., and Wilkie N. MAPKs: new targets for neurodegeneration. Expert Opin. Ther. Targets 7 (2003) 187-200
13. Hetman M., and Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem. 271 (2004) 2050-2055
14. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., and Akira S. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14 (2002) 1225-1231
15. Hua F., Ha T., Ma J., Li Y., Kelley J., Gao X., Browder I.W., Kao R.L., Williams D.L., and Li C. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol. 178 (2007) 7317-7324
16. Hua F., Ma J., Ha T., Kelley J., Williams D.L., Kao R.L., Kalbfleisch J.H., Browder I.W., and Li C. Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J. Neuroimmunol. 199 (2008) 75-82
17. Hua F., Ma J., Ha T., Xia Y., Kelley J., Williams D.L., Kao R.L., Browder I.W., Schweitzer J.B., Kalbfleisch J.H., and Li C. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190 (2007) 101-111
18. Jin X., Qin Q., Tu L., Zhou X., Lin Y., and Qu J. Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Mol. Vis. 17 (2007) 1953-1961
19. Kirschning C.J., and Schumann R.R. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr. Top Microbiol. Immunol. 270 (2002) 121-144
20. Leemans J.C., Stokman G., Claessen N., Rouschop K.M., Teske G.J., Kirschning C.J., Akira S., van der Poll T., Weening J.J., and Florquin S. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115 (2005) 2894-2903
21. Lehnardt S., Lehmann S., Kaul D., Tschimmel K., Hoffmann O., Cho S., Krueger C., Nitsch R., Meisel A., and Weber J.R. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 190 (2007) 28-33
22. Lu Y.C., Yeh W.C., and Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 42 (2008) 145-151
23. Martin S., Dicou E., Vincent J.P., and Mazella J. Neurotensin and the neurotensin receptor-3 in microglial cells. J. Neurosci. Res. 81 (2005) 322-326
24. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
25. Ojaniemi M., Glumoff V., Harju K., Liljeroos M., Vuori K., and Hallman M. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33 (2003) 597-605
26. Porter A.G., and Jänicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6 (1999) 99-104
27. Reglodi D., Tamas A., Somogyvari-Vigh A., Szanto Z., Kertes E., Lenard L., Arimura A., and Lengvari I. Effects of pretreatment with PACAP on the infarct size and functional outcome of rat permanent focal cerebral ischemia. Peptides 23 (2002) 2227-2234
28. Romashkova J.A., and Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401 (1999) 86-90
29. Sakata Y., Dong J.W., Vallejo J.G., Huang C.H., Baker J.S., Tracey K.J., Tacheuchi O., Akira S., and Mann D.L. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H503-H509
30. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5 (1999) 554-559
31. Shen X.D., Ke B., Zhai Y., Gao F., Busuttil R.W., Cheng G., and Kupiec-Weglinski J.W. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am. J. Transplant 5 (2005) 1793-1800
32. Shimamura N., Matchett G., Yatsushige H., Calvert J.W., Ohkuma H., and Zhang J. Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke 37 (2006) 1902-1909
33. Shioda N., Han F., Morioka M., and Fukunaga K. Bis (1-oxy-2-pyridinethiolato) oxovanadium (IV) enhances neurogenesis via phosphatidylinositol 3-kinase/Akt and extracellular signal regulated kinase activation in the hippocampal subgranular zone after mouse focal cerebral ischemia. Neuroscience 155 (2008) 876-887
34. Stoll G. Inflammatory cytokines in the nervous system: multifunctional mediators in autoimmunity and cerebral ischemia. Rev. Neurol. 158 (2002) 887-891
35. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., and Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3 (2002) 392-398
36. Tounai H., Hayakawa N., Kato H., and Araki T. Immunohistochemical study on distribution of NF-kappaB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin. Metab. Brain Dis. 22 (2007) 89-104
37. Zhang J.X., Wu H.S., Wang H., Zhang J.H., Wang Y., and Zheng Q.C. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J. Gastroenterol. 11 (2005) 4423-4426
38. Ziegler G., Harhausen D., Schepers C., Hoffmann O., Röhr C., Prinz V., König J., Lehrach H., Nietfeld W., and Trendelenburg G. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359 (2007) 574-579